Magali De Bruyn
Leuven, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
The Ulcerative Colitis Response Index for Detection of Mucosal Healing in Patients Treated With Anti-tumour Necrosis Factor.
Journal: Journal of Crohn's & colitis
Published: October 20, 2019
Failure of MMP-9 Antagonists in IBD: Demonstrating the Importance of Molecular Biology and Well-Controlled Early Phase Studies.
Journal: Journal of Crohn's & colitis
Published: June 25, 2018
Evidence to Support Monitoring of Vedolizumab Trough Concentrations in Patients With Inflammatory Bowel Diseases.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: January 12, 2018
NOD2 and bacterial recognition as therapeutic targets for Crohn's disease.
Journal: Expert opinion on therapeutic targets
Published: November 04, 2017
Comparisons of gut microbiota profiles in wild-type and gelatinase B/matrix metalloproteinase-9-deficient mice in acute DSS-induced colitis.
Journal: NPJ biofilms and microbiomes
Published: August 22, 2017
Inhibition of gelatinase B/MMP-9 does not attenuate colitis in murine models of inflammatory bowel disease.
Journal: Nature communications
Published: July 12, 2016
The molecular biology of matrix metalloproteinases and tissue inhibitors of metalloproteinases in inflammatory bowel diseases.
Journal: Critical reviews in biochemistry and molecular biology
Published: July 01, 2016
Genetic Deletion of Tissue Inhibitor of Metalloproteinase-1/TIMP-1 Alters Inflammation and Attenuates Fibrosis in Dextran Sodium Sulphate-induced Murine Models of Colitis.
Journal: Journal of Crohn's & colitis
Published: October 12, 2015
A Matrix-based Model Predicts Primary Response to Infliximab in Crohn's Disease.
Journal: Journal of Crohn's & colitis
Published: July 08, 2015
Last Updated: 09/26/2026